Literature DB >> 29894910

Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016.

M Eugenia Socías1, Evan Wood1, Thomas Kerr1, Seonaid Nolan1, Kanna Hayashi2, Ekaterina Nosova3, Julio Montaner4, M-J Milloy5.   

Abstract

BACKGROUND: A cascade of care framework has been proposed to identify and address implementation gaps in addiction medicine. Using this framework, we characterized temporal trends in engagement in care for opioid use disorder (OUD) in Vancouver, Canada.
METHODS: Using data from two cohorts of people who use drugs, we assessed the yearly proportion of daily opioid users achieving four sequential stages of the OUD cascade of care [linkage to addiction care; linkage to opioid agonist treatment (OAT); retention in OAT; and stability] between 2006 and 2016. We evaluated temporal trends of cascade indicators, adjusting for socio-demographic characteristics, HIV/HCV status, substance use patterns, and social-structural exposures.
RESULTS: We included 1615 daily opioid users. Between 2006 and 2016, we observed improvements in linkage to care (from 73.2% to 78.9%, p = <0.001), linkage to (from 69.2% to 70.6%, p = 0.011) and retention in OAT (from 29.1% to 35.5%, p = <0.001), and stability (from 10.4% to 17.1%, p = <0.001). In adjusted analyses, later calendar year of observation was associated with increased odds of linkage to care (Adjusted Odds Ratio [AOR] = 1.02, 95% Confidence Interval [CI]: 1.01-1.04), retention in OAT (AOR 1.02, 95% CI: 1.01-1.04) and stability (AOR = 1.03, 95% CI: 1.01-1.05), but not with linkage to OAT (AOR 1.00, 95% CI: 0.98-1.01).
CONCLUSIONS: Temporal improvements in OUD cascade of care indicators were observed. However, only a third of participants were retained in OAT in 2016. These findings suggest the need for novel approaches to improve engagement in care for OUD to address the escalating opioid-related overdose crisis.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Addiction; Buprenorphine/naloxone; Cascade of care; Methadone; Opioid agonist therapy; Opioid use disorder; Performance metrics; Quality indicators

Mesh:

Substances:

Year:  2018        PMID: 29894910      PMCID: PMC6062451          DOI: 10.1016/j.drugalcdep.2018.04.026

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  39 in total

Review 1.  Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies.

Authors:  Louisa Degenhardt; Chiara Bucello; Bradley Mathers; Christina Briegleb; Hammad Ali; Matt Hickman; Jennifer McLaren
Journal:  Addiction       Date:  2010-11-04       Impact factor: 6.526

2.  Adopting the 'cascade of care' framework: an opportunity to close the implementation gap in addiction care?

Authors:  M Eugenia Socías; Nora Volkow; Evan Wood
Journal:  Addiction       Date:  2016-07-13       Impact factor: 6.526

Review 3.  The effectiveness of patient navigation to improve healthcare utilization outcomes: A meta-analysis of randomized controlled trials.

Authors:  Sobia F Ali-Faisal; Tracey J F Colella; Naomi Medina-Jaudes; Lisa Benz Scott
Journal:  Patient Educ Couns       Date:  2016-10-17

4.  Unintended impacts of regulatory changes to British Columbia Methadone Maintenance Program on addiction and HIV-related outcomes: An interrupted time series analysis.

Authors:  M Eugenia Socías; Evan Wood; Ryan McNeil; Thomas Kerr; Huiru Dong; Jean Shoveller; Julio Montaner; M-J Milloy
Journal:  Int J Drug Policy       Date:  2017-04-25

5.  Barriers to use of free antiretroviral therapy in injection drug users.

Authors:  S A Strathdee; A Palepu; P G Cornelisse; B Yip; M V O'Shaughnessy; J S Montaner; M T Schechter; R S Hogg
Journal:  JAMA       Date:  1998-08-12       Impact factor: 56.272

6.  Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.

Authors:  Bobbi Jo H Yarborough; Scott P Stumbo; Dennis McCarty; Jennifer Mertens; Constance Weisner; Carla A Green
Journal:  Drug Alcohol Depend       Date:  2016-01-06       Impact factor: 4.492

7.  A call for evidence-based medical treatment of opioid dependence in the United States and Canada.

Authors:  Bohdan Nosyk; M Douglas Anglin; Suzanne Brissette; Thomas Kerr; David C Marsh; Bruce R Schackman; Evan Wood; Julio S G Montaner
Journal:  Health Aff (Millwood)       Date:  2013-08       Impact factor: 6.301

Review 8.  Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.

Authors:  Luis Sordo; Gregorio Barrio; Maria J Bravo; B Iciar Indave; Louisa Degenhardt; Lucas Wiessing; Marica Ferri; Roberto Pastor-Barriuso
Journal:  BMJ       Date:  2017-04-26

Review 9.  Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis.

Authors:  Georgie J MacArthur; Silvia Minozzi; Natasha Martin; Peter Vickerman; Sherry Deren; Julie Bruneau; Louisa Degenhardt; Matthew Hickman
Journal:  BMJ       Date:  2012-10-03

10.  Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting.

Authors:  Julio S G Montaner; Viviane D Lima; P Richard Harrigan; Lillian Lourenço; Benita Yip; Bohdan Nosyk; Evan Wood; Thomas Kerr; Kate Shannon; David Moore; Robert S Hogg; Rolando Barrios; Mark Gilbert; Mel Krajden; Reka Gustafson; Patricia Daly; Perry Kendall
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

View more
  25 in total

1.  Comparing Canadian and United States opioid agonist therapy policies.

Authors:  Kelsey C Priest; Lauren Gorfinkel; Jan Klimas; Andrea A Jones; Nadia Fairbairn; Dennis McCarty
Journal:  Int J Drug Policy       Date:  2019-02-11

2.  Motivations to initiate injectable hydromorphone and diacetylmorphine treatment: A qualitative study of patient experiences in Vancouver, Canada.

Authors:  Samara Mayer; Al Fowler; Isabella Brohman; Nadia Fairbairn; Jade Boyd; Thomas Kerr; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2020-09-16

3.  Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.

Authors:  N A Mohd Salleh; N Fairbairn; S Nolan; R Barrios; J Shoveller; L Richardson; M-J Milloy
Journal:  HIV Med       Date:  2019-07-29       Impact factor: 3.180

4.  Trajectories of retention in opioid agonist therapy in a Canadian setting.

Authors:  M Eugenia Socías; Huiru Dong; Evan Wood; Rupinder Brar; Lindsey Richardson; Kanna Hayashi; Thomas Kerr; M-J Milloy
Journal:  Int J Drug Policy       Date:  2020-02-09

5.  Hepatitis C continuum of care and utilization of healthcare and harm reduction services among persons who inject drugs in Seattle.

Authors:  Judith I Tsui; Claire M Miller; John D Scott; Maria A Corcorran; Julia C Dombrowski; Sara N Glick
Journal:  Drug Alcohol Depend       Date:  2018-12-26       Impact factor: 4.492

6.  Monitoring opioid addiction and treatment: Do you know if your population is engaged?

Authors:  José Tomás Prieto; Dean McEwen; Arthur J Davidson; Alia Al-Tayyib; Lisa Gawenus; Sridhar R Papagari Sangareddy; Joshua Blum; Seth Foldy; Judith C Shlay
Journal:  Drug Alcohol Depend       Date:  2019-07-06       Impact factor: 4.492

7.  The impact of the opioid crisis on U.S. state prison systems.

Authors:  Christy K Scott; Michael L Dennis; Christine E Grella; Allison F Mischel; John Carnevale
Journal:  Health Justice       Date:  2021-07-24

8.  Findings from the recovery initiation and management after overdose (RIMO) pilot study experiment.

Authors:  Christy K Scott; Michael L Dennis; Christine E Grella; Lisa Nicholson; Jamie Sumpter; Rachel Kurz; Rod Funk
Journal:  J Subst Abuse Treat       Date:  2019-08-07

9.  Impact of migration from an illicit drug scene on hospital outcomes among people who use illicit drugs in Vancouver, Canada.

Authors:  Tara Beaulieu; Kanna Hayashi; Huiru Dong; Kora DeBeck; Andrew Day; Rachael McKendry; Gaganpreet Kaur; Rolando Barrios; M-J Milloy; Lianping Ti
Journal:  Drug Alcohol Rev       Date:  2020-06-02

10.  Inpatient Addiction Medicine Consultation and Post-Hospital Substance Use Disorder Treatment Engagement: a Propensity-Matched Analysis.

Authors:  Honora Englander; Konrad Dobbertin; Bonnie K Lind; Christina Nicolaidis; Peter Graven; Claire Dorfman; P Todd Korthuis
Journal:  J Gen Intern Med       Date:  2019-12       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.